Clinical studies recruiting near Herston

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Royal Brisbane and Womens Hospital · Amgen · NCT07037433 A Platform Trial for Gram Negative Bloodstream Infections
NA · Royal Brisbane and Women's Hospital · Sunnybrook Health Sciences Centre · NCT06537609 BMB-101 in Absence Epilepsy and DEE
Phase 2 · Royal Brisbane and Womans Hospital · Bright Minds Biosciences Pty Ltd · NCT06401538 Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living
Phase 3 · Kailera Clinical Site · Kailera · NCT07284979 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Phase 3 · Royal Brisbane & Women's Hospital · Longboard Pharmaceuticals · NCT06660394 Study of HX15001 in Adult Healthy Volunteers.
Phase 1 · Q-Pharm Pty Ltd. · Helixon Biotechnology (Suzhou) Co., Ltd · NCT06999720 ROADMAP Clinical Trial
Phase 4 · Royal Brisbane and Women's Hospital · University of Newcastle, Australia · NCT06771050 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Royal Brisbane and Women s Hospital · Biogen · NCT06962800 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Royal Brisbane and Women's Hospital · Boehringer Ingelheim · NCT07220083 A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (R
Phase 1 · Nucleus Network Brisbane · Capstan Therapeutics · NCT06917742 Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Phase 2/Phase 3 · Royal Brisbane and Women's Hospital · Exelixis · NCT06943755 A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lu
Phase 2 · Royal Brisbane and Women's Hospital · Johnson & Johnson Enterprise Innovation Inc. · NCT06667908 Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18
Phase 1 · Site # 0361001 · Sanofi · NCT07516418 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05939414 Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Phase 2 · Royal Brisbane and Womens Hospital · Canadian Cancer Trials Group · NCT05640999 Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
Phase 4 · Royal Brisbane and Women's Hospital · Todd C. Lee MD MPH FIDSA · NCT06637332 A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers
Phase 2 · The University of Queensland · Western Sydney Local Health District · NCT05509153 Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
Phase 3 · Royal Brisbane and Women's Hospital · The University of Queensland · NCT04939935 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · Royal Brisbane and Women's Hospital ( Site 3009) · Merck Sharp & Dohme LLC · NCT03486873 Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressur
Phase 3 · Royal Brisbane and Womens Hospital · Amgen · NCT07226765 Safety and Efficacy of HB-1 for Post-Traumatic Stress Disorder
Phase 2 · Paratus Clinical Research Brisbane · HB BioTech, LLC · NCT07499440 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET
Phase 3 · Local Institution - 0055 · Bristol-Myers Squibb · NCT06976203 International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Phase N/A · Royal Brisbane & Women's Hospital · Prostate Cancer Clinical Trials Consortium · NCT03151629 PRECISION-TBI - An Observational Study of Patients With Moderate to Severe Traumatic Brain Injury
Phase N/A · Royal Brisbane and Women's Hospital · Australian and New Zealand Intensive Care Research Centre · NCT05855252 ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
Phase 3 · Royal Brisbane and Women's Hospital · Australian and New Zealand Intensive Care Research Centre · NCT04588311 A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Mye
Phase 1 · Royal Brisbane and Women'S Hospital · Incyte Corporation · NCT05936359 Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adu
Phase 2/Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06780670 A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT06679101

Look up another city

Look up another condition